DesignMedix, Inc develops drugs to overcome drug resistance in multiple diseases, and has a malaria drug ready for human trials, to be sponsored by the NIH.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free